Piper Sandler Upgrades Organon to Neutral, Raises Price Target to $14
Benzinga Newsdesk 6 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Piper Sandler analyst David Amsellem upgrades Organon (NYSE:OGN) from Underweight to Neutral and raises the price target from $5 to $14.
Piper Sandler analyst David Amsellem upgrades Organon (NYSE:OGN) from Underweight to Neutral and raises the price target from $5 to $14.